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Abstract We studied the effect of point mutation within the
putative 11th transmembrane domain (TM11) of the Na+/H+
exchanger NHE1 on the plasma membrane expression. Of the 19
mutants tested, two mutants (Tyr454 or Arg458 replaced by Cys)
were retained in the endoplasmic reticulum. Interestingly, Y454C
was expressed on the cell surface when one of the endogenous
cysteine residues at position 8, 133, 421, or 477 was substituted
with alanine. Random mutagenesis at Cys8 and its surrounding
residues in the cytosolic N-tail revealed that replacement of Cys8
with Ala was the only identified single residue mutation that
rescued Y454C. These results suggest that the abnormal
conformation of the region of TM11 containing the Y454C
mutation is compensated by the second mutation within other
domains such as the N-tail. This approach may provide evidence
for the interdomain interaction in NHE1. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
Key words: Na/H exchanger; Plasma membrane targeting;
Membrane topology; Transmembrane domain;
Site-directed mutagenesis ; Revertant
1. Introduction
The plasma membrane Na/H exchanger (NHE) is an
amiloride-sensitive electroneutral transporter that catalyzes
H extrusion coupled to Na in£ux. The ¢rst cloned exchang-
er isoform NHE1 [1] is ubiquitously expressed and plays an
important role in the regulation of intracellular pH (pHi) and
cell volume (see [2,3] for review). To date, at least six di¡erent
NHE isoforms are known to exist in the mammalian tissues
[2,3]. All the NHE isoforms share a common structure that is
separated into two major functional domains, the N-terminal
membrane domain (V500 amino acids (aa)) involved in ami-
loride-sensitive Na/H exchange and the C-terminal regula-
tory cytoplasmic domain (V300 aa) [4]. The amino acid se-
quence of the membrane domain except the N-terminus
(V100 aa) is well conserved among NHE isoforms, suggesting
that it may form essentially the same tertiary structure in
di¡erent isoforms. However, the precise transmembrane struc-
ture of NHE is still largely unknown.
Based on cysteine accessibility analysis, we have recently
presented a novel topology model of NHE1 comprising 12
membrane-spanning segments (see Fig. 1A) [5]. We have pro-
vided evidence that the short cytosolic N-tail is retained in the
mature protein without cleavage by a signal peptidase. Fur-
thermore, we proposed that the 19 aa region from Gln449 to
Tyr467, which was mapped to the extracellular loop based on
hydropathy analysis, forms a new transmembrane segment
(TM11) in NHE1, because cysteines incorporated into this
region were not accessible to biotin maleimide from either
side of the membrane, whereas those incorporated at posi-
tions at aa 447^448 and aa 468^476 were accessible to the
same reagent from the internal and the external sides of
the membrane, respectively ([5], and unpublished observa-
tion). This putative TM11 contains a glycine-rich motif
(454YGGLRGA) that is well conserved among all NHE iso-
forms and could thus be important for the function of the
exchanger.
During our analysis of properties of cysteine-scanning mu-
tants, we discovered that single amino acid substitutions at
two positions within the putative TM11 prevent export of
NHE1 mutant proteins from the endoplasmic reticulum
(ER) and thereby block their surface expression. Furthermore,
we observed that introduction of several second mutations
could rescue the plasma membrane targeting of such expres-
sion-de¢cient mutant proteins, suggesting functional interac-
tions between the ¢rst and the second mutation sites.
2. Materials and methods
2.1. Materials
3,3P-Dihexyloxacarbocyanine iodide (DiOC6(3)) was purchased
from Molecular Probes Inc. The amiloride derivative 5-(N-ethyl-N-
isopropyl) amiloride (EIPA) was a gift from New Drug Research
Laboratories of Kanebo, Ltd. (Osaka, Japan). 22NaCl was purchased
from NEN Life Science Products. Rabbit polyclonal antibody (RP-cd)
against human NHE1 was described previously [6]. All other chem-
icals were of the highest purity available.
2.2. Cell culture and cDNA transfection
The NHE-de¢cient cell line (PS120) [7] kindly provided by Dr. J.
Pouysse¤gur (Nice, France) and the corresponding transfectants were
maintained as described [5]. All cDNA constructs were transfected
into PS120 cells by the calcium phosphate^DNA co-precipitation
technique [4] and stable clones were selected by the repetitive H-
killing selection procedures [4,8]. In some experiments, pSV-neo was
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co-transfected with NHE1 mutant plasmids and single stable clones
were isolated after selection with G418 (geneticin).
2.3. Construction of NHE1 mutant plasmids
The plasmids including cDNA encoding NHE1 cloned into mam-
malian expression vector pECE were described previously [4,5]. The
cysteine-free form (substituted with Ala) of NHE1 (designated as Cys-
less NHE1) and some of its mutant derivatives were also described [5].
All the constructs used in this study were produced by a polymerase
chain reaction (PCR)-based strategy as described previously [4] and
their sequences were con¢rmed by DNA sequencing.
2.4. Mutagenesis with random oligonucleotides
For the random mutagenesis within the N-tail of NHE1, we syn-
thesized an antisense primer 5P-GAAGATCCGATGTGGAGAGAG-
NNNNNNNNNCGGAGACCGCAGAACCAT-3P containing mixed
nucleotides (N) corresponding to aa 7^9 of NHE1 and a complemen-
tary sense primer 5P-CTCTCTCCACATCGGATCTTC-3P against a
portion of antisense primer. DNA fragments produced by PCR
were digested and inserted into HindIII and XhoI sites of a mutant
cDNA (Y454C). After bacterial transformation, plasmids were pre-
pared from approximately 13 000 colonies of Escherichia coli, trans-
fected into PS120 cells seeded on 30 dishes and stable clones were
selected over 3 weeks by repetitive H-killing selection procedures.
Chromosomal DNA was prepared from cells, subjected to PCR re-
actions using two primers containing appropriate DNA sequences
from the vector (pECE) and NHE1 cDNA. Sequences incorporated
into chromosomal DNA were con¢rmed by sequencing PCR frag-
ments.
2.5. Immuno£uorescence microscopy
Cells grown on 60-mm dishes were ¢xed and permeabilized with
cold methanol, and blocked as reported previously [9]. Cells were then
incubated with polyclonal anti-NHE1 antibody that was preabsorbed
with the permeabilized exchanger-de¢cient PS120 cells, followed by
£uorescent staining with the rhodamine-labeled second antibody.
After being washed with phosphate-bu¡ered saline (PBS), cells were
further stained for 1 min with 1 WM DiOC6(3). The stained cells were
imaged on a £uorescent microscope equipped with CoolSNAP imag-
ing system (RS Photometrics).
2.6. Surface labeling of NHE1 mutants
Surface labeling of NHE1 mutants expressed in the plasma mem-
brane was performed essentially as described previously [5]. Cells were
washed with PBSCM (PBS containing 0.1 mM CaCl2 and 1 mM
MgCl2, pH 8.3) and incubated for 1 h at room temperature with
1 mM N-hydroxysuccinimidobiotin (NHS-biotin, Pierce) in PBSCM.
Cells were solubilized with lysis bu¡er containing 1% Triton X-100
and biotinylated proteins were recovered with streptavidin-agarose
beads (Pierce) as described previously [5].
2.7. Others
Giemsa staining was performed essentially as described previously
[1]. Cells were washed with PBS, ¢xed with 10% formaldehyde and
incubated for 20 min in Giemsa solution (5% in water). Dishes were
washed with water, dried and photographed. Immunoblot analysis of
NHE1 protein was performed as described [6]. The EIPA-sensitive
22Na uptake activity was measured using pH-clamped cells
(pHi = 5.6) with K-nigericin as in our previous study [10].
Fig. 1. Stable expression of various mutant NHE1s. A: A topology model of NHE1 reported previously [18]. B and C: Cells seeded on 60-mm
dishes were transfected with 10 Wg each plasmid and selected over 3 weeks by repetitive H-killing selection procedures. Cells were visualized
by Giemsa staining. Control: no transfection.
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3. Results and discussion
We introduced 19 cysteine substitutions (one at a time) at
positions of aa 447^465 in the putative TM11 of NHE1 (Fig.
1A). We transfected these mutants into exchanger-de¢cient
PS120 cells and subjected them to H-killing selection to elim-
inate cells lacking the Na/H exchange activity [8]. We
found that cells transfected with Y454C or R458C did not
survive this selection procedure (Fig. 1B, data for R458C
not shown), indicating that these mutants were not function-
ally expressed in the plasma membrane. In contrast, cells ex-
pressing mutants carrying substitution of Tyr454 with hydro-
phobic aromatic residues Phe and Trp survived the selection
e⁄ciently (data not shown), while those transfected with
Y454A survived less e⁄ciently (Fig. 1B). On the other hand,
mutants with substitution of Arg458 with basic residues Lys
and His survived well (data not shown). Since H-killing se-
lection did not produce stable transfectants with Y454C or
R458C, we isolated single clones expressing these proteins
after subjecting cells to G418 selection. Indeed, these cloned
cells did not exhibit any EIPA-sensitive 22Na uptake (see
Fig. 2).
Intriguingly, when Y454C was constructed from the Cys-
less NHE1 plasmid, its transfectants survived H-killing se-
lection e⁄ciently (Fig. 1B, cl-Y454C), indicating that this mu-
tant is functionally expressed in the plasma membrane. Since
all endogenous cysteines had been replaced by Ala in the Cys-
less NHE1, we introduced single Cys to Ala substitutions at
six positions of endogenous cysteines in the N-terminal mem-
brane domain of the Y454C mutant derived from the wild-
type NHE1. As shown in Fig. 1C, Y454C was rescued by
substitution of Cys477 with Ala, but less e⁄ciently by the
Ala substitution of Cys8, Cys113, or Cys421. In contrast,
Y454C was not rescued by the same Ala substitution of
Cys133 or Cys212 (Fig. 1C).
The rescue of Y454C by the second mutation C8A is par-
ticularly interesting, because Cys8 is far from Tyr454 in the
primary structure of NHE1. We introduced random muta-
tions into the DNA segment of Y454C corresponding to po-
sitions 7^9 of NHE1 (Ile-Cys-Gly) and transfected the resul-
tant constructs into PS120 cells. We isolated 36 single stable
clones by H-killing selection and analyzed DNA sequences
of 30 plasmids incorporated into chromosomes of these trans-
fectants. Interestingly, 21 clones were found to contain an
alanine codon (GCT) at position 8 (Table 1). We did not
detect any other single amino acid substitutions, suggesting
that rescue of Y454C may occur through replacement of
Cys8 speci¢cally with Ala, although we do not know why
other alanine codons were not detected. In seven other res-
cued clones, aa 7^9 were simultaneously replaced with three
exogenous amino acids (Table 1). Of note, six of seven clones
contained charged amino acids (Glu, Lys, Arg, or His). In
order to con¢rm the roles of these exogenous amino acids
in the rescue of Y454C, we produced several Y454C mutants
carrying these amino acid substitutions by site-directed muta-
genesis (see Fig. 2). We also deleted aa 7^9 (Y454C/v7^9)
from the Y454C mutant. As expected, these transfectants
were able to exhibit relatively high EIPA-sensitive 22Na up-
take activity (Fig. 2). In addition, EIPA concentration depen-
dence of 22Na uptake was not signi¢cantly di¡erent between
the wild-type NHE1 and a rescued mutant Y454C/C8A;
83.8 þ 8.8 and 102.0 þ 8.9 nM (IC50 þ S.E.M. obtained from
Fig. 2. Na/H exchange activity of cells expressing various mutant
NHE1s. EIPA-sensitive 22Na uptake was measured as described
under Section 2. Data are means þ S.D. of three determinations.
Table 1
Results from the random mutagenesis experiment
Nucleotide sequences of
recovered clones
Amino acid
change
The number
of clones
ATC TGT GGC (wild-type) ICG
ATC GCT GGC IAG 21
CCC GAG CAT PEH 1
GTT AAG AGA VKR 1
AGG GGA CGC RGR 1
GGT CCT AAT GPN 1
GGT AAG CGC GKR 1
AAA GAG ACC KET 1
CGG GAG CAG REH 1
ATC TGT GGC No change 2
Nucleotide and amino acid sequences for aa 7^9 of the wild-type
NHE1 are shown in the second column.
Fig. 3. Immunoblotting and surface labeling of various mutant
NHE1s. Cells expressing NHE1 variants were labeled with NHS-bi-
otin, solubilized with the lysis bu¡er, and then treated with streptav-
idin-agarose. Total proteins (50 Wg) (A) or streptavidin-recovered
proteins (B) were separated on 8.5% polyacrylamide gel electropho-
resis and visualized by immunoblot with anti-NHE1 antibody.
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curve ¢tting), respectively, suggesting that the structural integ-
rity of EIPA-binding site was preserved upon rescued expres-
sion.
Fig. 3A shows immunoblot of expressed proteins stained
with anti-NHE1 antibody. We observed two forms of the
wild-type exchanger with a high (V110 kDa) or low (V90
kDa) apparent molecular weight, which are thought to be
N- and O-linked glycosylated mature protein or high man-
nose-containing immature protein, respectively [11]. We de-
tected only the immature form in cells expressing Y454C
and R458C, whereas we detected both forms in cells express-
ing mutants carrying additional substitutions (Fig. 3A).
Fig. 3B shows results obtained from surface labeling of ex-
changer proteins with NHS-biotin. We observed the biotiny-
lation of expressed proteins for mutants other than Y454C
and R458C.
Fig. 4 shows immuno£uorescence staining with anti-NHE1
antibody for cells expressing several NHE1 variants. Most of
Y454C and R458C proteins were localized in the intracellular
membranes that were stained with the ER marker DiOC6(3),
but they were not detected in the plasma membrane (Fig. 4).
In contrast, the wild-type NHE1 and the rescued mutants
Y454C/C8A and Y454C/C477A were expressed in the plasma
membrane as well as in the ER. As reported previously [12],
we often observed the accumulation of NHE1 in the periph-
eral regions of cells that are probably focal adhesions.
In this study, we found that single cysteine substitution at
Tyr454 or Arg458 strongly inhibits the surface expression of
NHE1 by apparently preventing its export from the ER.
These residues are located within a segment corresponding
to Gln449^Tyr467 which was predicted to form a mem-
brane-spanning segment (TM11) based on our topological
analysis of NHE1 as brie£y discussed in Section 1 (see also
Fig. 1). This putative TM11 is predicted to contain a non-K-
helical glycine-rich motif (454YGGLRGA) and the C-terminal
K-helix (461IAFSLGY). The former non-K-helical region in the
putative TM11 might be important for ion transport by the
NHE, as similar helix-unwound regions near Gly residues in
the membrane have been shown to form Ca2-binding sites in
the recently reported crystal structure of the SR Ca2-ATPase
[13]. Consistent with this view, this glycine-rich motif is highly
conserved among mammalian NHE isoforms and NHE ho-
mologs from lower animals and appears to be important for
the exchanger function as suggested by our recent ¢nding that
several point mutations incorporated into this region greatly
in£uence pHi dependence of Na/H exchange (Wakabaya-
shi, S. et al., unpublished observation).
As stated above, we found that the Y454C and R458C
mutant proteins were mostly retained in the ER membrane
(Fig. 4). This suggests that these mutant proteins may be
properly translocated to the ER membrane. The ER has the
ability to recognize, retain and degrade misfolded or incom-
Fig. 4. Immuno£uorescence microscopy of cells expressing various mutant NHE1s. Cells grown on 60-mm dishes were stained with anti-NHE1
antibody followed by incubation with rhodamine-labeled second antibody as described under Section 2. Cells were further stained for 1 min
with the ER marker DiOC6(3). Two images for rhodamine and DiOC6(3) were merged with the aid of imaging software. Bars: 30 Wm.
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pletely folded proteins and thereby ensures the structural in-
tegrity of synthesized proteins [14,15]. As suggested from the
study of the processing of several proteins, the quality control
system in the ER appears able to recognize subtle structural
di¡erences in proteins [15]. Although it is currently not known
whether the Y454C and R458C proteins are still able to cata-
lyze Na/H exchange, the quality control mechanisms in the
ER clearly recognized abnormal conformations of these mu-
tant proteins. However, the scope and nature of the structural
alteration in the NHE1 protein caused by Y454C or R458C
mutation are not clear at present, although many misfolded
proteins have been shown to inappropriately expose hydro-
phobic surfaces that are normally buried in the protein’s in-
terior or at the interface with other subunits [17,18]. The heat
shock protein 70 may possibly be involved in the processing of
NHE1 protein in the ER, because these proteins have been
shown to interact with each other [16].
We found that several second point mutations (C8A,
C113A, C421A, and C477A) at least partially rescued the sur-
face expression of Y454C, suggesting that these mutations
somehow rearrange the structure of Y454C. An example for
such revertants was reported in CFTR in which expression of
v508 was rescued by the second mutation at a nearby residue
(R553M or R553Q) [19]. According to our topology model of
NHE1, Cys421 and Cys477 are mapped to TMs 10 and 12
neighboring TM11, respectively, while Cys113 is mapped to
TM2 (see Fig. 1). These endogenous cysteines are not acces-
sible to biotin maleimide from the aqueous environment [5].
The simplest interpretation of the present results would be
that the regions of TMs 2, 10 and 12 containing the second
mutation sites may interact directly with the region of TM11
containing Tyr454, thereby suppressing the e¡ect of the
Y454C mutation. However, it is also possible that the correc-
tion of misfolding in the mutant protein may occur through a
long-range structural alteration involving interactions between
distant TMs.
In contrast to cysteines within putative TMs, Cys8 is
mapped to the cytosolic N-tail which is far from Try454 in
the primary structure of NHE1. Cys8 is accessible to biotin
maleimide from the cytosolic side of the plasma membrane [5].
Random mutagenesis revealed that a change of Cys to Ala is
the only single amino acid substitution at position 8 in the N-
tail that permits the rescue of plasma membrane targeting of
the Y454C mutant. These data suggest that misfolding of
NHE1 protein caused by the Y454C mutation was corrected
at least partially by a relatively speci¢c structural alteration in
the N-tail, allowing some of this mutant protein to escape the
ER quality control mechanisms. Thus, the C8A mutation in
the N-tail of NHE1 induces a change in the conformation of
the Y454C mutant. Recently, the short N- or C-tail region has
been reported to be important for the correct folding and
proper membrane targeting of the SR Ca2-ATPase [20] or
the Na/Ca2 exchanger [21], respectively. In the crystal struc-
ture of the SR Ca2-ATPase [13], a signi¢cant portion of the
N-tail appears to be closely associated with the actuator do-
main of the ATPase that is considered to be involved in the
transmission of major conformational changes. On the basis
of these ¢ndings and the speci¢c requirement of Ala at posi-
tion 8 for the rescue of the plasma membrane targeting of the
mutant protein (Table 1), we speculate that the N-tail of
NHE1 may interact directly with the region of TM11 contain-
ing Tyr454. However, we do not exclude the possibility that
two regions only interact randomly during protein folding.
The amino acid sequence of the N-tail is highly variable
among NHE isoforms (see [2,3] for review) and the N-tails
of NHE isoforms except NHE1 may be cleaved o¡ during
protein processing, suggesting that the interaction between
N-tail and TM11 could be speci¢c for NHE1.
In summary, we found that the surface expression of NHE1
is prevented by single amino acid substitutions within the
putative TM11, which is rescued by second amino acid point
mutations within other TMs and at the cytosolic N-tail. The
second mutations corrected the abnormal conformations in-
duced by the ¢rst mutation, thereby permitting NHE1 mutant
protein to at least partially escape quality control in the ER.
Although the underlying mechanism for this phenomenon re-
mains unclear, this work provides the ¢rst evidence support-
ing the interdomain interaction in the membrane domain of
NHE1.
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